Johnson & Johnson (JNJ) Notes Payables (2009 - 2026)
Johnson & Johnson (JNJ) posted Notes Payables of $11.7 billion for Q2 2026, down 33.04% sequentially from $17.5 billion in Q1 2026, and up 1.44% YoY from $11.5 billion in Q2 2025.
Johnson & Johnson (JNJ) Notes Payables (2009 - 2026) Analysis & Trends
Johnson & Johnson has reported Notes Payables for 18 years, with the latest figure at $11.7 billion in Q2 2026.
- Quarterly Notes Payables rose 1.44% year-over-year to $11.7 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $11.7 billion (up 1.44% YoY) and the FY2025 annual result came in at $8.5 billion, up 41.99% from the prior year.
- Notes Payables fell to $11.7 billion in Q2 2026 per JNJ's latest filing, from $17.5 billion in the prior quarter.
- Over five years, Notes Payables peaked at $18.0 billion in Q2 2023 and troughed at $3.5 billion in Q4 2023.
- A 5-year average of $8.7 billion and a median of $8.5 billion in 2025 frame the typical range for Notes Payables.
- The widest YoY moves for Notes Payables: up 318.41% in 2023, down 72.95% in 2023.
- Over 5 years, Notes Payables stood at $4.4 billion in 2022, then slipped by 21.99% to $3.5 billion in 2023, then jumped by 73.37% to $6.0 billion in 2024, then soared by 41.99% to $8.5 billion in 2025, then jumped by 37.63% to $11.7 billion in 2026.
- According to Business Quant data, Notes Payables over the past three periods registered $11.7 billion, $17.5 billion, and $8.5 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.18 Bn | 632.42 Bn | 17.26 Bn |
| 2 | AbbVie | 470.13 Bn | 463.56 Bn | 12.70 Bn |
| 3 | Merck | 376.16 Bn | 369.02 Bn | 12.21 Bn |
| 4 | Novartis Ag | 302.69 Bn | 295.00 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.73 Bn | 252.83 Bn | 12.86 Bn |
| 6 | Amgen | 236.53 Bn | 222.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 183.21 Bn | 180.03 Bn | 6.22 Bn |
| 8 | Pfizer | 160.17 Bn | 148.47 Bn | 10.94 Bn |
| 9 | Gsk | 105.91 Bn | 101.75 Bn | 8.24 Bn |
| 10 | Sanofi | 55.25 Bn | 47.87 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | 11.69 Bn |
| Mar 29, 2026 | 17.46 Bn |
| Dec 28, 2025 | 8.50 Bn |
| Sep 28, 2025 | 6.39 Bn |
| Jun 29, 2025 | 11.53 Bn |
| Mar 30, 2025 | 13.90 Bn |
| Dec 29, 2024 | 5.98 Bn |
| Sep 29, 2024 | 4.46 Bn |
| Jun 30, 2024 | 9.86 Bn |
| Mar 31, 2024 | 8.55 Bn |
| Dec 31, 2023 | 3.45 Bn |
| Oct 1, 2023 | 3.87 Bn |
| Jul 2, 2023 | 11.70 Bn |
| Apr 2, 2023 | 17.98 Bn |
| Jan 1, 2023 | 12.76 Bn |
| Oct 2, 2022 | 4.42 Bn |
| Jul 3, 2022 | 4.31 Bn |
| Apr 3, 2022 | 4.30 Bn |
| Jan 2, 2022 | 3.77 Bn |
| Oct 3, 2021 | 3.80 Bn |